Advaxis Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer
Strategic transition to Investigator sponsored IND from previously announced Advaxis sponsored INDInitiation of investigator sponsored Phase 1 study of ADXS-504 […]